TRIDENT LIFELINE
Quarterly Results Analysis [Dec2024]
TRIDENT LIFELINE Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 Audited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹12 Cr | ₹15 Cr | ₹13 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr |
Expenses | ₹8 Cr | ₹11 Cr | ₹11 Cr | ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
Operating Income | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹0 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit After Tax | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
EPS | ₹2.42 | ₹2.69 | ₹1.99 | ₹0.94 | ₹0.54 | ₹1.22 | ₹1.72 | ₹1.75 |
Industry Peers & Returns | 1W | 1M | 1Y |
TRIDENT LIFELINE | 16.7% | -2.3% | 41.8% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -7.5% | 2.3% |
DIVIS LABORATORIES | -0.2% | -9.9% | 60.4% |
CIPLA | 4.4% | -0.6% | -1% |
TORRENT PHARMACEUTICALS | 4.8% | -2.9% | 15.4% |
DR REDDYS LABORATORIES | NA | -9.4% | -10.2% |
MANKIND PHARMA | -0.7% | -8.8% | 7.1% |
ZYDUS LIFESCIENCES | 2.5% | -11.4% | -5.5% |
LUPIN | 2.9% | -8.1% | 20.9% |
TRIDENT LIFELINE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -23.45 % |
Y-o-Y | 156.94 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹12 Cr | -23.45 | |
Sep2024 | ₹15 Cr | 17.45 | |
Jun2024 | ₹13 Cr | 85.53 | |
Dec2023 | ₹7 Cr | 54.03 | |
Sep2023 | ₹5 Cr | -46.74 | |
Jun2023 | ₹9 Cr | 2.19 | |
Mar2023 | ₹8 Cr | -10.09 | |
Dec2022 | ₹9 Cr | - |
TRIDENT LIFELINE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 0.62 % |
Y-o-Y | 8,054.00 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹4 Cr | 0.62 | |
Sep2024 | ₹4 Cr | 62.21 | |
Jun2024 | ₹2 Cr | 75.42 | |
Dec2023 | ₹1 Cr | 2,748.00 | |
Sep2023 | ₹0 Cr | -97.17 | |
Jun2023 | ₹2 Cr | -9.54 | |
Mar2023 | ₹2 Cr | -1.37 | |
Dec2022 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 31.41 % |
Y-o-Y | 3,062.39 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 34.47% | 31.41 | |
Sep2024 | 26.23% | 38.13 | |
Jun2024 | 18.99% | -5.43 | |
Dec2023 | 20.08% | 1,742.20 | |
Sep2023 | 1.09% | -94.66 | |
Jun2023 | 20.41% | -11.49 | |
Mar2023 | 23.06% | 9.71 | |
Dec2022 | 21.02% | - |
TRIDENT LIFELINE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -9.04 % |
Y-o-Y | 312.76 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹3 Cr | -9.04 | |
Sep2024 | ₹3 Cr | 75.45 | |
Jun2024 | ₹2 Cr | 52.62 | |
Dec2023 | ₹1 Cr | 69.47 | |
Sep2023 | ₹1 Cr | -55.85 | |
Jun2023 | ₹1 Cr | -29.08 | |
Mar2023 | ₹2 Cr | -1.84 | |
Dec2022 | ₹2 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 18.81 % |
Y-o-Y | 60.59 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 21.6 % | 18.81 | |
Sep2024 | 18.18 % | 49.38 | |
Jun2024 | 12.17 % | -17.77 | |
Dec2023 | 14.8 % | 10.04 | |
Sep2023 | 13.45 % | -17.08 | |
Jun2023 | 16.22 % | -30.59 | |
Mar2023 | 23.37 % | 9.15 | |
Dec2022 | 21.41 % | - |
TRIDENT LIFELINE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -10.04 % |
Y-o-Y | 348.15 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹2.42 | -10.04 | |
Sep2024 | ₹2.69 | 35.18 | |
Jun2024 | ₹1.99 | 111.70 | |
Dec2023 | ₹0.94 | 74.07 | |
Sep2023 | ₹0.54 | -55.74 | |
Jun2023 | ₹1.22 | -29.07 | |
Mar2023 | ₹1.72 | -1.71 | |
Dec2022 | ₹1.75 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD